Shelton Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-45,300
| Closed | -$671K | – | 677 |
|
|
2022
Q3 | $671K | Sell |
45,300
-7,700
| -15% | -$114K | 0.03% | 271 |
|
|
2022
Q2 | $834K | Hold |
53,000
| – | – | 0.04% | 267 |
|
|
2022
Q1 | $1.43M | Buy |
53,000
+5,000
| +10% | +$135K | 0.05% | 241 |
|
|
2021
Q4 | $1.78M | Hold |
48,000
| – | – | 0.06% | 239 |
|
|
2021
Q3 | $2.29M | Buy |
48,000
+10,000
| +26% | +$478K | 0.09% | 213 |
|
|
2021
Q2 | $1.29M | Buy |
38,000
+7,800
| +26% | +$264K | 0.05% | 257 |
|
|
2021
Q1 | $1.25M | Buy |
+30,200
| New | +$1.25M | 0.04% | 272 |
|